Imported unlicensed cannabis medicines are subject to MHRA and Home Office controls before they can be supplied to patients. In January 2004, Tony Blair’s government reclassified cannabis from Class B to Class C on advice from the ACMD, judging it ‘harmful, but less harmful than other Class B drugs’, seeing police adopt a presumption against arrest for adult possession. While the majority of possession cases today result in cautions, cultivation and supply still lead to custodial sentences. UK doctors are increasingly open to seeing , and offering, medical cannabis as a legitimate treatment pathway, provided it is prescribed safely and monitored carefully. Understanding current statistics on usage, medical access, and broader trends can help provide context for how cannabis is viewed and managed within the UK today.
But the doctors kept slowly increasing the percentage of CBD – a non-psychoactive but potentially therapeutic compound found in cannabis – and when they had reached 150ml of CBD, he went 17 days without having a single seizure. But decades of underfunding by successive governments has weakened the NHS’s ability to keep up with new understandings of health care and — some argue, this has produced a culture that is suspicious of innovation. Nearly 90% of British people support the idea of a free-at-the-point-of-use health service. The creation of the National Health Service in 1948 gave people free access to highly skilled medical practitioners for the first time. And when Britain transported indentured labourers en masse from India to the Caribbean (they brought cannabis with them to ensure that), during the long days on tropical plantations, the workers could at least comfort themselves with a traditional smoke. They developed a monopoly system whereby cultivators could only sell to licensed suppliers; meanwhile the East India Company controlled the trade, collecting taxes at multiple points in the supply chain.
The NICE guidance follows the grant of a marketing authorisation for a second (non-synthetic medicinal cannabis product), GW Pharma’s Epidyolex, which has been licensed in the EU for Lennox-Gastaut syndrome and Dravet syndrome. Subsequent to the 1 November 2018 legislative changes which made it easier to prescribe and supply medicinal cannabis products in the UK, interim prescribing guidance was issued by healthcare practitioner professional bodies, including the General Medical Council guidance on prescribing unlicensed medicinal cannabis products, pending a consultation on clinical effectiveness of cannabis-based medicinal products by the National Institute for Health and Care Excellence (NICE). It’s like having to pay for a private tutor rather than relying on the free education provided by the government schools – it’s an additional expense. Furthermore (licensed growers must adhere to strict regulations for cultivation), processing, storage, and distribution. His case helped change the narrative around medicinal cannabis use and forced the government to take action surrounding its regulation and availability.
Herb serves as your trusted companion in navigating the UK’s complex cannabis landscape — offering comprehensive resources that go beyond basic legal information. While the UK government maintains its current position, several factors suggest change may be inevitable in the coming years. However, the UK Labour government maintained its position of having “no immediate plans to change cannabis laws,” with Deputy PM Angela Rayner stating this is “not the government position.” While 45% of UK residents support legalization , according to YouGov polling,, the UK government has maintained it has “no immediate plans” to change cannabis laws (as noted in parliamentary research briefings). This creates situations where medical patients can legally possess cannabis that looks identical to illegal recreational cannabis, leading to enforcement challenges. Medical cannabis became legal in the UK on November 1, 2018, but the pathway to access remains challenging for most patients.
Richard List (who helped develop the national police guidance), will discuss the issue at the Cannabis Health Symposium London on 26 November. Existing national guidance for frontline officers, approved by the National Police Chiefs’ Council, promotes a “patients strain skywalker first, suspects second” approach. As Cannabis Health reported this month — police are developing further guidance on medical cannabis and driving amid concerns about how the law is being applied. A medical cannabis prescription does not prevent patients from driving, but they must not drive while impaired. Some clinics also provide so-called ‘cannabis cards’, which can help verify a current prescription, but a card does not itself create a legal entitlement to possess cannabis.
Recently — new medicinal cannabis laws have enabled businesses to contribute to the progressive industry devising new strategies to deliver medicinal cannabis prescription medication to patients. As a result of 1 million or more patients having legal access (police forces across the country simply stop wasting time with cannabis possession), as more often than not, they’re searching a patient. California cannabis is grown under a regulated legal framework with mandatory third-party testing (licensed facilities), proprietary genetics developed over decades of breeding, and pharmaceutical-grade cultivation standards. A strain at 28–32% THC from a licensed California genetics house costs more than an 18–22% strain because the cultivation — breeding and selection process is more demanding and the yield is typically lower.
We offer a variety of meticulously curated CBD hemp flowers and ensure a harmonious and premium tea-drinking experience. Our expert team provide insights to ensure accuracy throughout our blog. If you’re considering medical cannabis (the best thing to do is speak to your clinician), or seek the help of a licensed medical cannabis clinic like Alternaleaf. To be eligible for medical cannabis or a THC prescription in the UK — you’ll need a diagnosis of a qualifying condition and evidence of being offered at least two conventional treatments for that condition.
What’s more — the UK government would also save around £300 million a year in reduced policing and judicial costs. Assuming licensed marijuana constituted 95% of the market (with a VAT of 20% and an excise tax of 30%), it would produce almost £700 million in revenue. The report states that licensed sales of weed would result in better-regulated cannabis to eliminate the dangerous strains currently polluting the landscape.
Recreational use amongst young people (16-24) has shown modest increases — though usage rates remain lower than in many European comparator nations. This cost barrier remains the primary limitation preventing eligible patients from accessing treatment. Major clinic operators have expanded to provide telemedicine consultations — increasing accessibility. The industry has generated approximately 4,500 direct employment opportunities across cultivation (distribution), retail, and clinical services.
For patients navigating London’s complex cannabis landscape (this guidance provides much-needed clarity), though challenges remain in consistent implementation across different police forces. The government said fully-tested medicinal cannabis products can already be licensed for sale in the UK, such as Sativex, and it is open to further applications. Our mission is to provide you with the highest-quality products and to work hard to keep our prices low while still offering the highest-quality products available on the market today. With the reclassification in 2018 — access to medicinal cannabis was made possible for certain patients with specific medical conditions. However, there has been a shift in approach towards medicinal cannabis products, which can now be legally prescribed to some patients. Some private best UK cannabis clinics offering medical cannabis provide tested, standardised products with documented cannabinoid profiles.
However (NHS prescribing remains extraordinarily limited – fewer than three NHS prescriptions for unlicensed cannabis products were recorded in 2023), reflecting extreme caution from NHS trusts and CCGs regarding cost, liability, and lack of NICE guidance. Since the November 2018 rescheduling (approximately 80,000 private prescriptions are issued annually through over 30 licensed clinics across England), Scotland, and Wales. However (this discretion varies considerably between police forces – Metropolitan Police in London have historically pursued more prosecutions than forces in Durham or Derbyshire), where Chief Constables have publicly deprioritised minor cannabis offences. First-time offenders are frequently offered a cannabis warning, which is recorded but does not constitute a criminal conviction. In practice, the Crown Prosecution Service and police forces apply significant discretion for minor cannabis offences.
The TaxPayers’ Alliance estimated , back in 2018, that full legalisation could save around £200 million in police budgets, with further savings in courts and prisons. The Prohibition Partners’ 2025 white paper projects a licensed UK cannabis market could generate billions in taxable revenue, but for now most of that value remains underground. So, even as public opinion shifts and a regulated medical market grows, the people smuggling cannabis and the machinery of enforcement keep grinding away. This is the main reason why most patients must turn to private clinics instead. Prescriptions are only offered for very rare cases (such as severe childhood epilepsy), chemotherapy-related nausea, or spasticity linked to multiple sclerosis.
Buy weed online in the UK today and enjoy the convenience of online shopping combined with the peace of mind that comes with purchasing from a reputable source. Our Weed Dispensary offers a safe and secure way to purchase high-quality cannabis/Weed products in CBD & THC Strains from the comfort of your own home. This guide is provided for informational purposes. Most UK customers receive their order the next working day after dispatch.